Use of rhodamine 123 in the treatment of the pollard iii rat prostate adenocarcinoma
- 1 June 1990
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 44 (2) , 103-108
- https://doi.org/10.1002/jso.2930440209
Abstract
Significant destruction of the Pollard III rat prostate adenocarcinoma was achieved by treatment with rhodamine 123 at a dosage of 15 mg/kg every other day for 33 to 38 days. Injection of tumor remnants into untreated animals produced no tumor regrowth. Our data have demonstrated rhodamine 123 to be a significant drug for the management of the very aggressive Pollard III tumor.Keywords
This publication has 11 references indexed in Scilit:
- Chapter 7 Fluorescent Labeling of MitochondriaPublished by Elsevier ,1988
- Rhodamine-123 as effective agent in rat prostate tumor R3327-H: Preliminary reportUrology, 1986
- Metastatic spread of the PAIII prostatic adenocarcinoma after implantation in the tail of the ratThe Prostate, 1986
- SELECTIVE TOXICITY OF RHODAMINE-123 IN CARCINOMA-CELLS INVITRO1983
- Cytochemical localization of lipid, peroxidase, and carbohydrate substances in the dunning prostatic adenocarcinoma R3327H: An ultrastructural analysisJournal of Surgical Oncology, 1980
- Localization of mitochondria in living cells with rhodamine 123.Proceedings of the National Academy of Sciences, 1980
- Spontaneous Prostate Adenocarcinomas in Aged Germfree Wistar Rats2JNCI Journal of the National Cancer Institute, 1973
- ROLE OF THE GROUND SUBSTANCE IN ATROPHY OF NORMAL AND MALIGNANT PROSTATIC TISSUE FOLLOWING ESTROGEN ADMINISTRATION AND ORCHIECTOMYJournal of Clinical Endocrinology & Metabolism, 1954
- QUANTITATIVE STUDIES OF PROSTATIC SECRETIONThe Journal of Experimental Medicine, 1940